Efficacy of Attention Bias Modification vs. Placebo for Social Anxiety Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorTel Aviv University
About this trial
This study examines whether a computerized attention-training intervention called attention bias modification (ABM) can reduce symptoms of social anxiety disorder (SAD) in adults, and whether symptom improvement is specifically related to changes in attentional processing or to nonspecific factors such as expectancy and placebo effects.
Eligibility criteria
Qualifiers
Adults aged 18-65 years
Primary diagnosis of generalized Social Anxiety Disorder based on clinical evaluation, the MINI International Neuropsychiatric Interview (MINI), and a Liebowitz Social Anxiety Scale (LSAS) score greater than 50
Normal or corrected-to-normal vision without color blindness
Sufficient Hebrew proficiency to complete clinical interviews, self-report questionnaires, and computerized cognitive tasks
Disqualifiers
Previous participation in attention bias modification training using a dot-probe task
Previous participation in eye-tracking-based attention training
Current diagnosis of Post-Traumatic Stress Disorder
Current or past diagnosis of psychotic disorder or bipolar disorder
Trial design
Treatments tested in this trial
- Dot-Probe Attention Bias Modification (ABM)
- Placebo Training
Treatment groups
90 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov